MedTrace Logo

Laser Treatment for Lichen Sclerosus

NCT06389071 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-23

No results posted yet for this study

Summary

Fractional ablative laser treatment for Lichen Sclerosus lesion

Conditions

  • Lichen Sclerosus Lesion

Interventions

DEVICE

Fractional 2940 nm Laser

Fractional 2940 nm Laser

Sponsors & Collaborators

  • Sciton

    lead INDUSTRY

Principal Investigators

  • Josee Parent, MD · Clinique Medicale Uro-Gyneco de l'Abitibi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2027-07-20
Completion
2027-12-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06389071 on ClinicalTrials.gov